logo

For the Inventor, By the Inventor

Bissersheim, Germany

Rainer Schlecker

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Basf Aktiengesellschaft. Active years: 1984-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rainer Schlecker. Retrieved from https://idiyas.com/inventor/rainer-schlecker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:

goldMedal17 out of 10,816 
 
Basf Aktiengesellschaft
 patents

Years Active: 1984-1997

Loading Chart...
Areas of Expertise:
Triazolopyrimidones
Benzofurancarboxamides
Antiarrhythmic Agents
Triazoloquinazolines
Therapeutic Agents
Pyridazinone-Imines
Sulfonates
Thiazolyloxamic Acids
Benzofuran Derivatives
Central Nervous Disorders
Modulator Agents
Antiulcerogenic Agents
17 patents (USPTO):Explore Patents
1. 5654310 - Triazolopyrimidones their preparation and use (1997-08-05),
2. 5631261 - Triazoloquinazolines, their preparation and use (1997-05-20),
3. 5622953 - 1-amino-3-phenoxy propane derivatives as modulator agents and their (1997-04-22),
4. 5612344 - Triazoloquinazolines for the treatment of central nervous disorders (1997-03-18),
5. 5424330 - Benzofurancarboxamides having basic substituents, the preparation (1995-06-13),
6. 5356901 - Benzofurancarboxamides having basic substituents, the preparation (1994-10-18),
7. 5264452 - Benzofurancarboxamides and therapeutic agents (1993-11-23),
8. 5214047 - Tetracyclic quinazoline derivatives, effective as antiarrythmic agents (1993-05-25),
9. 5153228 - 9-amino-2-phenylbicyclo[3.3.1]nonanes and (1992-10-06),
10. 5151437 - Benzofurancarboxamides having basic substituents and therapeutic agents (1992-09-29),
11. 5039701 - Novel benzofuran derivatives and therapeutic agents containing them (1991-08-13),
12. 4945114 - Therapeutic agents containing enantiomers of propafenone (1990-07-31),
13. 4845096 - Benzofuran derivatives and antiulcerogenic agents containing same (1989-07-04),
14. 4820821 - Novel pyridazinone-imines and their physiologically tolerated addition (1989-04-11),
15. 4618622 - Sulfonates of hydroxycoumarins (1986-10-21),

Title: Rainer Schlecker: Innovator in Pharmaceutical Chemistry

Introduction

Rainer Schlecker is a notable inventor based in Bissersheim, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for disease control. With a total of 17 patents to his name, his work has had a considerable impact on the industry.

Latest Patents

Among his latest patents are "Triazolopyrimidones their preparation and use" and "Triazoloquinazolines, their preparation and use." The first patent focuses on triazolopyrimidines of a specific formula, detailing their preparation and potential applications in controlling diseases. The second patent also emphasizes the preparation and use of triazoloquinazolines, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Rainer has worked with prominent companies such as BASF Aktiengesellschaft, where he has honed his skills and contributed to various projects. His experience in these organizations has allowed him to advance his research and develop groundbreaking inventions.

Collaborations

Throughout his career, Rainer has collaborated with esteemed colleagues, including Hans P Hofmann and Liliane Unger. These partnerships have enriched his work and fostered a collaborative environment for innovation.

Conclusion

Rainer Schlecker's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His innovative work continues to influence the development of new compounds for disease control.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…